Time to treatment response in first-episode schizophrenia: should acute treatment trials last several months?
Juan A Gallego, Delbert G Robinson, Serge M Sevy...
https://pubmed.ncbi.nlm.nih.gov/21939612Completed
Phase 4
Age: 16Years - 40Years
All Genders
ID00000374
Preventing Morbidity in First-Episode Schizophrenia
Led by Northwell Health · Updated on 2012-01-13
125
Participants Needed
2
Research Sites
N/A
Total Duration
On this page
Sponsors
N
Northwell Health
Lead Sponsor
N
National Institute of Mental Health (NIMH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This 3-year study will determine if the antipsychotic medications olanzapine (Zyprexa®) and risperidone (Risperdal®) can help patients with first-episode schizophrenia.
CONDITIONS
Official Title
Treatment for First-Episode Schizophrenia
Who Can Participate
Age: 16Years - 40Years
All Genders
Eligibility Criteria
You may qualify if you...
- First episode schizophrenia, schizophreniform disorder or schizoaffective disorder
You will not qualify if you...
- Prior treatment with antipsychotic medications.
Trial Site Locations
Total: 2 locations
1
Hillside Hospital
Glen Oaks, New York, United States, 11004
Status Unknown
2
Bronx-Lebanon Hospital Center
The Bronx, New York, United States, 10456
Status Unknown
Loading map...
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here